GNRH1 and polycystic ovary syndrome: This is the first clinical study to compare the effect of adding short-term metformin to GnRH antagonist protocol on follicular fluid redox balance markers TAS, TOS and OSI, as well as total number of oocytes, mature oocytes and fertilization rates in CC-resistant PCOS patients.